Lung Cancer Treatment at IV One:

Chemotherapy, Targeted and Immunotherapy Infusions

At a Glance

What it is: Outpatient infusion therapy for lung cancer, including chemotherapy, targeted and immunotherapy infusions, plus supportive care.
Who leads it: Your own oncologist prescribes the protocol, and our licensed team delivers it in private infusion suites at IV One.
What to expect: Advanced, evidence-based care in a calm, private setting, with same day discharge and close coordination with your oncologist.

Lung cancer treatment at IV One Health in Riyadh is delivered through outpatient infusion therapy, including chemotherapy, targeted and immunotherapy infusions, alongside supportive care. Each protocol is prescribed by your oncologist and delivered in private infusion suites by our licensed medical team.

What is lung cancer infusion therapy?

Lung cancer is usually treated systemically, meaning the medication travels through the bloodstream to reach cancer cells wherever they are. Infusion therapy delivers that medication directly into a vein, allowing precise dosing, faster action and closer monitoring during the session. At IV One Centre these infusions are provided in a calm, private outpatient setting, so you can receive advanced treatment without an overnight hospital stay.

Lung cancer is broadly divided into non-small cell lung cancer, which accounts for most cases, and small cell lung cancer. The distinction matters because it shapes which infusion protocols your oncologist will consider, and whether biomarker testing opens a targeted option.

Lung cancer infusion treatments at IV One Centre

Your oncologist selects the right combination for your tumor type, stage and biomarker profile. We deliver the prescribed protocol with precision and care, as part of our wider oncology infusion therapy service.

Infusion type	What it does	Typical use in lung cancer
Chemotherapy infusions	Targets and destroys rapidly dividing cancer cells.	Both non-small cell and small cell lung cancer, often in combination regimens.
Targeted therapy infusions	Blocks the specific molecular driver fueling tumor growth.	Tumors with a confirmed driver such as EGFR or ALK.
Immunotherapy infusions	Help the immune system recognize and attack cancer cells.	Widely used in non-small cell lung cancer, alone or with chemotherapy.
Supportive infusions	Provides hydration, anti-nausea medication and nutritional support.	Reducing side effects and protecting strength during treatment.

Supportive infusions can be scheduled around your treatment cycles on referrals. You can read more about supportive infusion care for lung cancer patients, or see the full scope of services on our conditions we treat page.

Working alongside your oncologist

We are a specialized infusion center, not a replacement for your treating oncologist. Your specialist sets the diagnosis, requests the biomarker testing and determines the protocol. Our clinical team delivers it with close coordination and reports each cycle back the same day, so your care stays consistent, safe and joined up from consultation to every infusion session.

Why choose IV One for lung cancer care in Riyadh

Licensed oncology infusion clinic in Riyadh, holding a Ministry of Health license and Council of Health Insurance accreditation
Oncology trained pharmacist preparing every cytotoxic and targeted infusion in a sterile compounding suite.
Chemotherapy certified nurses who stay close throughout the session
Private infusion suites designed for comfort during longer sessions
Supportive care infusions to protect quality of life during treatment
Same day cycle reporting to your oncologist for continuity of care

What to expect during your visit

Each infusion is planned around your protocol and confirmed with you in advance. You are welcomed into a private suite, cared for by our medical team throughout the session, and able to return home the same day. Our goal is to deliver more than medication: precision cancer care with compassion, dignity and hope.

Frequently asked questions

Where can I get lung cancer treatment in Riyadh?

IV One Centre is a licensed outpatient infusion center in Riyadh, providing lung cancer infusion therapy prescribed by your oncologist. Treatments include chemotherapy, targeted therapy and immunotherapy infusions, delivered in private suites by an experienced medical team.

What infusion treatments are used for lung cancer?

Lung cancer is commonly treated with chemotherapy, targeted therapy and immunotherapy infusions, often in combination. Many patients also receive supportive infusions such as hydration, anti-nausea medication and nutritional support. Your oncologist selects the right combination for your diagnosis.

Do I need biomarker testing before targeted therapy?

Yes. Your oncologist will usually request biomarker or molecular testing on your tumor tissue. The results show whether your cancer carries a driver such as EGFR or ALK, which determines whether a targeted infusion is an option for you.

Do I need biomarker testing before targeted therapy?

Is lung cancer chemotherapy given as an outpatient?

Yes. At IV One Centre, lung cancer chemotherapy, targeted therapy and immunotherapy are delivered on an outpatient basis, so you receive treatment and return home the same day, without an overnight hospital stay.

How long does a lung cancer infusion session take?

Session length depends on the medication and regimen prescribed by your oncologist, ranging from under an hour to several hours. Our team confirms your schedule in advance so you can plan each visit with confidence.

For more answers, visit our IV therapy FAQs.

Speak to IV One

If your oncologist has prescribed chemotherapy, a targeted agent, immunotherapy or a combination for lung cancer, our team can administer it for you as outpatient care in Riyadh. We will coordinate directly with your oncologist, walk you through what each treatment day will look like, and book your first session at a time that works for you and your family.

Sources and references: American Cancer Society, National Cancer Institute, American Society of Clinical Oncology (ASCO), National Comprehensive Cancer Network (NCCN), European Society for Medical Oncology (ESMO), Saudi Food and Drug Authority (SFDA), Saudi Ministry of Health (MOH), Council of Health Insurance (CHI).